Health Rounds: AstraZeneca drug reduces lung disease flare-ups in late-stage trials
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By Nancy Lapid Sept 9 (Reuters) – Today we feature data from studies being presented at the ongoing European Respiratory Society Congress in Barcelona. EXPERIMENTAL DRUG REDUCES L























